Microbial mimics supersize the pathogenic self-response.

Area of Science:

• Immunology
• Microbiology
• Autoimmunity

Background:

• Microbial mimicry is a proposed mechanism in autoimmunity, where microbial antigens trigger responses against self-antigens.
• Type 1 diabetes (T1D) is an autoimmune disease characterized by the destruction of insulin-producing beta cells.

Purpose of the Study:

• To investigate the role of microbial mimicry in T1D by identifying specific microbial peptides.
• To characterize the interaction between microbial peptides and autoreactive T cells in T1D.

Main Methods:

• Analysis of naturally processed peptides from Klebsiella oxytoca.
• Assessment of peptide binding affinity to autoreactive T cell receptors associated with T1D.
• Characterization of T cell activation by microbial peptides.

Main Results:

• A peptide from Klebsiella oxytoca was identified as a superagonist for autoreactive T cells in T1D.
• This microbial superagonist binds T cell receptors thousands of times more effectively than self-peptides.
• The findings narrow the search for relevant microbial mimic sequences.

Conclusions:

• Microbial superagonists, like the one identified, represent a refined model for microbial mimicry in T1D.
• These findings have implications for developing novel interventions and personalized monitoring strategies for T1D.
• The concept of microbial superagonists may extend to other autoimmune diseases involving microbial mimicry.